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2PROTON NMR RELAXATION TIMES OF HUMAN BLOOD SAMPLES AT
1.5 T AND IMPLICATIONS FOR FUNCTIONAL MRI
ABSTRACT
To further investigate the dependency of fMRI signal changes on echo time TE,
we measured T2 and T2* values, obtained from human blood samples at
various oxygenation levels and used them in a simple model to calculate signal
enhancement in fMRI. In addition, the longitudinal relaxation time T1 of human
blood was determined for reference. All measurements were performed at 23°C
to reduce blood cell metabolism during the measurement procedure. At 23°C
T1 values of 1434±53 ms for venous and 1435±48 ms for arterial human blood
were obtained after correcting for hematocrit content, as hematocrit values
ranged from 28% to 34% only. The T2 relaxation times obtained are 181±23 ms
for venous and 254±26 ms for arterial human blood, T2* relaxation times
corrected for inhomogeneities of the static magnetic field (B0) are 42±2.8 ms  and
254±32 ms, respectively. Furthermore, the absolute and relative signal changes
in fMRI experiments are calculated. The results from the model calculations
reveal that contrast in fMRI can be optimised by choosing an appropriate echo
time.
Keywords: human blood, relaxation times, T1,T2,T2*, fMRI, model calculations
3INTRODUCTION
Contrast in functional magnetic resonance imaging (fMRI) mainly relies on
changes in regional cerebral blood flow and blood oxygenation level, however,
the relative contributions of the respective effects to observed signal changes
are still under debate. As they are not independent from each other, it has not
been possible yet to separate flow and blood oxygenation level dependend
(BOLD) effects in gradient-recalled echo fMRI quantitatively in vivo. However,
the latter effect alters the transverse relaxation time (T2) and the apparent
transverse relaxation time (T2*) of human blood (throughout the paper
relaxation times as well as relaxation rates (RX=1/TX) will be used depending
on which are more instructive). Therefore, the dependence of human blood T2
and T2* relaxation times on oxygen saturation is of some importance in
functional brain mapping by fMRI. One possible approach for a better
understanding of the BOLD effect in fMRI is to measure relaxation times of
human blood in vitro (i.e. at the same field strength, and with a comparable
shim and hardware performance many in vivo fMRI studies have been
performed) and to extrapolate to in vivo conditions by means of a theoretical
model without including the problems of movements artefacts. Furthermore,
functional contrast depends on the echo time chosen in the actual fMRI
experiment and may be used to differentiate (large) venous vessel "activation"
from cortical activation (Kim et al, 1994).
4MATERIALS AND METHODS
Blood Samples
Arterial and venous blood samples of a total of nine subjects (age: 30-70 years,
both sexes) were taken into a heparin coated vacutainer with an inner diameter
of 13 mm. The fraction of oxygenated red blood cells (blood oxygenation level Y
or HbO2 level) and hematocrit fraction were determined before and after the
MRI-measurement with a clinical hemoximeter ABL 330 or ABL 912 (ABL LIST
GesmbH, Austria) using the partial oxygen pressure and total hemoglobin
value at 37°C. Immediately after the determination of the blood gas values the
two tubes containing (arterial and venous) blood were placed in a test tube
holder inside the MR-Imager.
Reference substances
Three reference tubes containing deionised water with various concentrations
of manganese chloride (0.05mM and 0.08mM MnCl2 solution) and/or an
aqueous solution (0.072mM) of the contrast agent Magnevist“, a commonly
used contrast agent in clinical MR-investigations, were put into the test tube
holder together with the two blood sample tubes. The respective concentrations
were chosen to obtain relaxation times very similar to those of human blood.
5MRI experiments
All measurements were performed on a MAGNETOM SP4000 (SIEMENS
Inc.,Germany) clinical whole body system operating at 1.5 Tesla using a
standard circular polarized head coil. This setup is used in order to be closest to
the one used for in vivo fMRI experiments (e.g. Gomiscek et al, 1993; Moser et al,
1995). It is especially important to use the same magnetic field strength as
relaxation times of blood (T1/T2) measured at room temperature show a 4/10
fold variation with B0 varying from 10-500 MHz (see Stadelmann et al, 1991).
The sample holder standing in a bath of a 0.16 mM solution of MnCl2 (to soften
susceptibility differences at the blood-air surface and dephasing near the
menisci of the tubes) was placed inside a cylindrical pipe which fit into the head
coil. A transverse slice of 6 or 8 mm was selected along the axes of the tubes, in
order to gain the maximum signal from the sample tubes. The MnCl2 bath was
kept at constant temperature of about 23± 1°C throughout the whole
measurement to reduce blood cell metabolism during the measurement
procedure compared to 37°C.
T1 was determined using a saturation recovery sequence with four different
repetition times (TR=4000, 2000, 1000 and 500 ms) and a TE of 15 ms. T2 was
measured with a multiple spin echo sequence (TR=4000 ms; TE=25-495 ms,
echo delay of 15 ms, necho=32). Matrix size was 128x128 and the FOV was 200
mm.
A multiple gradient echo sequence applying 25 gradient echoes with two
different repetition times was used to measure T2*. The flip angle used was 40°.
Echo times range from 4 ms to 119 ms (echo delay: 4.6 ms) for the shorter
6repetition time (146 ms) and from 4 ms to 500 ms (the echo delay increases from
4.6 ms to 100 ms within one echo train) for the longer repetition time (507 ms),
respectively. The two different repetition times are used in order to improve the
fitting accuracy for the short (e.g. of blood sediment) as well as for the longer
T2* relaxation times (e.g. of blood plasma). The other sequence parameters are:
matrix size of 128x128 pixels, quadratic field of view of 200 mm, r.f. flip angle a
of 40°, readout bandwidth of 300 Hz/pixel. The measurement time for the T2*
measurement was 20 seconds for the short repetition time and 80 seconds for
the longer one. Total measurement time for one blood sample set (= one
experiment) was less than four hours including shimming.
Data evaluation
The MR images were evaluated with a fitting program based on the IDL
software package (Research Systems Inc., Boulder, CO). The number of pixels
included in a ROI exceeded 70 in order to obtain a reasonable mean signal
intensity for the fitting procedure. The position of the ROI within the tubes was
controlled for each echo time in order to eliminate partial volume effects of tube
or fluid surfaces. The ROI was therefore always smaller than the inner tube
diameter of 13 mm. The pixel intensities of this ROI were averaged over this
area for each echo time and fitted using a single-exponential least square fitting
procedure as Meyer et al (1995) reported that single-exponential fits perform
much better than bi-exponential algorithms applied to blood data.
Magnetic field homogeneity
B0 inhomogeneities influence the accurate estimation of (blood) T2*. This is
indicated by the following equation:
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R2’ reflects the influence of magnetic field variations, in this case either caused
by B0 inhomogeneities (R2'shim) as well as by (deoxygenated) blood cells
(R2'cells). Fully oxygenated blood is only slightly diamagnetic (Weisskoff and
Kiihne, 1992) and R2'cells for arterial blood is therefore small. The difference in
R2 and R2* relaxation times of arterial blood should therefore be dominated by
R2'shim. Thus, R2'shim may be obtained from R2 and R2* of arterial blood using
eq. 1. Subsequently, eq. 1 may then be used to calculate corrected R2* values of
venous blood, i.e. without the influence of B0 inhomogeneities.
Implications for fMRI at 1.5 Tesla
In order to demonstrate implications for fMRI of the brain, the data obtained
during the in vitro study of human blood have been used in model calculations
of fMRI signal enhancement. As the MR signal decays exponentially with time,
the relaxation times of venous and arterial human blood can be used for
calculating the remaining voxel signal as a function of echo time. The signal
difference at a certain echo time is proportional to the fMRI signal enhancement
between rest and stimulation, at least in voxels containing 100% blood. This
simple BOLD-based model already described by Menon et al (1993) is used to
describe absolute (DS, eq. 2) and relative signal enhancement (DS/S, eq. 3),
respectively:
DS S TE T stim TE T rest= ⋅ - - -0 2 2(exp ( / * ) exp ( / * )) (2)
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S0 is the voxel signal intensity at echo time TE=0. T2*rest is the T2* value of
human blood under resting conditions (i.e. no stimulation) and T2*stim is the
T2* value during stimulation (R2*stim and R2*rest are the inverse of T2*stim and
T2*rest).
The optimum echo time (TEopt) for fMRI-contrast may be calculated via the
maximum absolute signal, thus TEopt is obtained by differentiation of Eq. 2:
TEopt R rest R stim R rest R stim= -
- ⋅( * * ) ln( * / * )2 2
1
2 2 (4)
9RESULTS
Relaxation times
T1 and T2 relaxation times of human blood in vitro are given in the row ‘whole
blood’ in Tab. 1. Measured T2 relaxation times (Fig. 1; open circles) clearly
increase with higher oxygen saturation, as expected, and show the same
dependence on HbO2 level as given by Wright et al (1991) (see Fig. 1; solid line
shows the fit obtained by Wright et al, 1991).
T1 relaxation times of hematocrit and plasma (obtained from sedimented blood)
were used in the two-compartment fast-exchange model proposed by
Zimmerman and Brittin (1957), which can be adapted very well for blood
(Fullerton and Cameron, 1988) to calculate “whole blood“ relaxation times.
These calculated relaxation times (see Tab. 1) are in reasonble agreement with
measured whole blood values. This model is therefore used to correct
hematocrit depending T1 values in order to obtain data which may be
compared quantitatively to similar studies (see Tab. 3; corrected T1 values are
indicated with an asterisk). T1 and T2 relaxation times obtained for reference
solutions (also given in Tab. 1) show only small variations and are close to those
for human blood. They are therefore used to control reproducibility between
different experiments.
T2* relaxation times of human blood as well as of reference solutions are given
in Tab. 2. As mentioned above, T2* values are very sensitive to B 0
inhomogeneities. This may be seen from the short T2* relaxation times of the
reference solutions, compared to corresponding T2 values, and from the high
standard  deviations of T2* values, compared to those of T1 and T2 values.
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In order to get a better estimate of T2* relaxation times of whole blood, three
experiments were performed, where both T2 and T2* values were measured and
T2* values of whole blood were corrected with R2'shim as derived from arterial
T2* values and eq. 1 (see Tab. 2). Corrected T2* values are significantly higher
and show a much smaller standard deviation than the uncorrected ones (see
also Fig.1; open squares = corrected T2* values for oxygenated and
deoxygenated human blood).
From a particular experiment the dependence of relaxation time versus
increasing oxygen saturation can be shown more clearly. T2* measurements
were performed at the beginning and repeated after several hours when blood
oxygenation already changed due to the slow continuation of blood cell
metabolism (note: HbO2 level was determined immediately before and after
MRI measurements). T2* data (corrected as described above) are shown in Fig. 1
(open triangles). The dashed line shows the (least squares) fit using the model
proposed by Wright (1991):
R Y2 3 9 351 1
2* . ( )= + ⋅ - (5)
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DISCUSSION
Relaxation times
So far, only a few reports on human blood T1 and T2 at 1.5 T exist (Gomori et al,
1987; Wright et al, 1991; Stadelmann et al, 1991) and only one single study
reports T2*-values (Chien et al, 1994), with no T2 reference values given.
We obtained highly reproducible T1 values (relative SD £  5%) from blood
samples and reference solutions. In agreement with human blood data (Wright,
1991; Stadelmann, 1991) and rat blood measurements of Thulborn et al (1982),
this parameter is not sensitive to different blood oxygenation levels. However,
T1 is depending on parameters like magnetic field strength (Stadelmann, 1991),
temperature (Stadelmann, 1991) and hematocrit content (Fullerton and
Cameron, 1988). Due to the use of anticoagulants blood hematocrit value is
lower compared to average hematocrit values which normally range between
42% (female) and 47% (male) in large vessels (Miale, 1982). In order to obtain T1
values which can be compared quantitatively with published data, it is
necessary to correct for hematocrit content. This may be done by using an
average hematocrit value of 45% in the two compartment fast exchange model
mentioned above. The T1 values are then in reasonable agreement with
published data. A comparison of T1 relaxation times obtained in this study
(corrected T1 data are indicated by an asterisk) with published data, measured
under similar general conditions, is summarized in Tab. 3. However, Gomori et
al. (1987) found a variation depending on the oxygenation level (T1  (100%
HbO2) = 1180 ms and T1 (0% HbO2) = 1300 ms), which is not in agreement with
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data obtained by us and others (Thulborn, 1982) and cannot be explained by
them.
Highly reproducible T2 values could be obtained from reference solutions
(relative SD < 2%, except Magnevist“: relative SD = 7%; see Tab. 1). Due to
different HbO2 levels of blood samples, T2 standard deviations are larger than
that of reference solutions, but also show good reproducibility (relative SD £
13%; see Tab. 1). As can also be seen from Tab. 1, T2 relaxation times are shorter
for venous than for arterial blood, which is due to the diffusion of hydrogen
through magnetic field gradients generated by paramagnetic deoxyhemoglobin.
This is true for whole blood as well as for blood sediment. Based on the data
presented (see Tab. 3) and the fact that T2 is not very sensitive to changes in
hematocrit, temperature and field homogeneity, it is a perfect reference for data
comparison. The temperature dependence found by Stadelmann (1991) at 42
MHz shows a T2 increase of only 10% with temperature increasing from 23°C to
37°C.
T2* relaxation times show a stronger dependence on oxygenation level than T2.
This is due to dephasing of spins in regions of local magnetic field
inhomogeneities caused by paramagnetic deoxyhemoglobin of venous blood.
The reproducibility of T2* relaxation times is poor as they are very sensitive to
B0 inhomogeneity. This may be one reason why published T2* data of human
blood are sparse and, furthermore, T2* data which depend on the actual shim-
status are not very valuable. However, if T2 values are measured in addition to
T2* relaxation times, it is possible to account for deviations caused by B0
inhomogeneities and it is shown here that the correction algorithm applied
increases reproducibility dramatically. Recently, Chien et al (1994) obtained in
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vitro T2* relaxation times of 70, 95, and 185 ms for oxygenation levels of 73.6%,
82.5%, and 98.4%, respectively (see also Tab. 3; corrected T2* values obtained in
this study are indicated by an asterisk). In vivo they found T2* values of 142±30
ms and 241± 6 ms for oxygenation levels of 70% and 100%, respectively.
Obviously, their data are not very consistent. The differences between their and
our findings can probably be explained by the huge time spacing they use
between gradient echoes (20 ms seems to be rather long for the T2* expected)
and by the, therefore, small number of echoes recorded. In addition, the
measurement temperature was higher (37° C).
Calculated “whole blood” values from this study are in good agreement with
the results of real whole human blood except when diffusion through large
magnetic field gradients and B0 inhomogeneities play a role (i.e. venous T2 and
T2* values), which is not considered in the simple two compartment fast
exchange model.
Implications for fMRI at 1.5 Tesla
Eq. 5 may be used to calculate T2* relaxation rates at HbO2 levels estimated by
in vivo fMRI experiments in large venous vessels (Haacke et al, 1995; Haacke,
submitted). There, a Y of 0.55 has been found at resting conditions, which
increases by 0.15 during stimulation, resulting in a T2*rest of 13.4 ms and a
T2*stim of 28.2 ms. Taking these numbers into eqs. 2 and 3 we may estimate
absolute and relative signal increase to be expected in fMRI at 1.5 T. Model
calculations for a gradient echo sequence are given in Figs. 2 and 3, together
with the results for a spin echo sequence, again using Wright’s model and
corresponding T2 values (i.e. T2rest of 112 ms and a T2stim of 163 ms). The
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optimum echo time (TEopt) calculated via eq. 4 is 19 ms for the gradient echo
sequence and 134 ms for the spin echo sequence, too long to be of practical use.
As shown in Fig. 3, DS/S increases exponentially with increasing echo time in
gradient echo fMRI, whereas DS/S contributions originating from a spin echo
sequence can hardly be recorded at 1.5 T.
Fitting T2* values obtained from our in vitro study of human blood with the
model of Wright et al (1991) we assume that T2* and T2 values of fully
oxygenated blood are equal. This assumption seems to be very reasonable as
we observe a dramatic reduction of standard deviations of T2* values of venous
blood (i.e. from 19% to 7%) after the correction applied. In addition, a quite
large reduction of T2 values of fully oxygenated blood (in case that the weak
diamagnetism might reduce T2*) results in only minor changes of T2* values
used in the calculation of fMRI signal changes.
A comparison of DS/S calculated with the model proposed here and fMRI data
measured at various echo times with the same equipment, shows very
reasonable agreement (Barth et al, 1996). DS/S at echo times frequently used in
fMRI studies at 1.5 T (i.e. 40 to 60 ms) is about 5% to 10%, a range of signal
enhancements which were also obtained in various systematic studies (e.g.
Haacke et al, 1994; Moser et al, 1996). But at very long echo times (ª 130 ms) this
simple model cannot account for mechanisms like signal dephasing due to
partial volume effects (Haacke, 1996). This effect is one reason why the use of
very long echo times does not automatically increase signal enhancement in
fMRI (Barth, 1996). In addition, as the most relevant parameter in fMRI
postprocessing is contrast to noise (DS/N), it may be more important to
optimize the echo time to maximum absolute signal (DS). The optimum echo
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time at 1.5 Tesla (TEopt) estimated with this model is 19 ms, but this accounts
only for voxels with 100% blood. In case that other tissue, e.g. gray matter, is
picked up within the same voxel, TEopt should be longer. Thus, as empirically
chosen in most gradient echo fMRI studies at 1.5 T, it is preferable to use echo
times longer than 40 ms when fMRI signal changes from the small vessel
network in the human cortex are the target.
On the other hand, only extremely long TE's may reveal cortical activation at 1.5
T. In a comparative study (Kim, 1994) it was shown that only "activated" vessels
would be detected with short (TE = 10-20 ms) echo times at 4 T. Only if TE was
increased to 30-60 ms, vessels and cortical activation could be detected. For
gradient echo fMRI at 1.5 Tesla this would imply to chose TE's of about 70-140
ms. To our knowledge only one single study has been performed successfully at
1.5 T (Barth et al, 1997 in press) as SNR and magnetic field inhomogeneities are
extremely critical.
In summary/conclusion we could show that (a) relaxation times of human
blood at 1.5 T may be measured with reasonable accuracy in a clinical scanner,
(b) after proper correction in vitro T2* relaxation times of human blood may be
used to estimate fMRI signal enhancement at 1.5 T, and (c) very long echo times
may be advantageous for detecting "cortical" activation at 1.5 T. In contrast to
other published work so far we measured T1, T2 and T2* relaxation times of the
same human blood sample at different oxygenation levels in vitro and,
therefore, are able to estimate blood signal changes occurring in in vivo fMRI
studies quantitatively.
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T1 [ms] T2 [ms]
venous arterial venous arterial
whole blood 1582±35 (n=6) 1585±69 (n=5) 181±23 (n=3) 254±26 (n=3)
blood sediment 982±50 (n=5) 990±53 (n=5) 121±6 (n=5) 137±19 (n=5)
blood plasma 2308±89 (n=5) 2277±67 (n=5) 419±79 (n=5) 416±77 (n=5)
calculated values 1622±68 (n=4) 1622±68 (n=4) 235±15 (n=5) 253±31 (n=5)
MnCl2 (0.05 mM/l) 1359±79 (n=7) 184±4 (n=7)
MnCl2 (0.08 mM/l) 1304±31 (n=5) 185±4 (n=7)
Magnevist“
(0.072 mM/l)
1456±141 (n=7) 221±16 (n=8)
Tab. 1: T1 and T2 Relaxation times of venous (HbO2 = 71.9±2.6%) and arterial
(HbO2 = 96.7±1.6%) human blood samples (n = number of samples), as well as
those of reference substances measured at 1.5 T and 23° C. Data presented are
mean values ± one standard deviation.
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T2*[ms]
venous arterial
whole blood (n=5) 26±6 (23%) 71±28 (39%)
blood sediment (n=6) 21±8 37±18
blood plasma (n=6) 63±33 52±31
calculated values (n=6) 39±17 46±26
uncorrected whole blood (n=3) 28±5 (18%) 71±33 (46%)
corrected whole blood (n=3) 42±3 (7%) * 254±32 (13%) *
MnCl2 (0.05 mM/l) (n=11) 60±35
MnCl2 (0.08 mM/l) (n=11) 58±31
Magnevist“ (0.072 mM/l) (n=7) 35±7
Tab. 2: T2* relaxation times of venous and arterial human blood samples at the
same HbO2 levels as indicated in Tab. 2, as well as those of reference substances
measured at 1.5 T and 23° C. Corrected data are indicated by an asterisk. Data
presented are mean values ± one standard deviation (n =number of samples).
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HbO2
[%]
T [°C] w0
[MHz]
T1
[ms]
T2
[ms]
DTE
[ms]
T2*
[ms]
DTE [ms] n
Gomori et al 0 20 60 1300 140 4 - - 2
(1987) 100 20 60 1180 210 4 - - 2
Wright et al 70 37 63.3 - 183 12 - - 5
(1991) 96 37 63.3 - 252 12 - - 5
Stadelmann
et al (1991)
venous 20 63.3 1470 146 3 - - some
Chien et al 73.6 37 63.3 - - - 70 20 8
(1994) 98.4 37 63.3 - - - 185 20 8
This study 71.9 23 63.3 1434* 181 15 42 4.6 3-6
96.7 23 63.3 1435* 254 15 254 4.6 3-6
Tab. 3: Comparison of human blood relaxation times obtained at about 60 MHz.
The asterisk denotes that T1 values were corrected for normal in vivo hematocrit
content as described in the text.
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Figure Captions
Fig. 1: Dependence of T2 (open circles ±  SD) and T2* relaxation times on
oxygenation saturation of human blood in vitro. The solid line represents the fit
to T2 values obtained by Wright et al (1991). Data presented as open squares are
average T2*-values (n=5) with error bars indicating one standard deviation.
Open triangles show T2* data obtained from one single blood sample for
comparison. Dashed line results from fitting the Wright model to the corrected
in vitro blood T2* data obtained from this blood sample.
Fig. 2: Absolute signal increase (DS) expected from BOLD in fMRI experiments
at 1.5 T. Data shown assume that the voxel is filled 100% with blood. DS was
calculated using Eq. 2 with T2* values obtained from eq. 5. The solid line shows
DS of gradient echo fMRI (T2*rest= 13.4 ms, T2*stim= 28.2 ms), whereas the
dashed line shows DS of spin echo fMRI (T2rest = 112 ms, T2stim = 163 ms).
Fig. 3: Relative signal increase (DS/S) expected from BOLD in fMRI-images at
1.5 T, calculated by using Eq. 2 with the same relaxation times values as for DS
(Fig. 2). Again, the solid line indicates the expected signal increase obtained
from a gradient echo experiment, whereas the dashed line shows DS/S obtained
from a spin echo fMRI experiment.
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